1. Home
  2. GRPN vs ESPR Comparison

GRPN vs ESPR Comparison

Compare GRPN & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$25.61

Market Cap

989.5M

ML Signal

HOLD

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
ESPR
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
989.5M
816.9M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
GRPN
ESPR
Price
$25.61
$3.19
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$33.67
$8.75
AVG Volume (30 Days)
1.7M
16.8M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
$2,843,877,000.00
$403,135,000.00
Revenue This Year
$5.55
N/A
Revenue Next Year
$6.63
$12.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$9.17
$1.11
52 Week High
$35.35
$4.18

Technical Indicators

Market Signals
Indicator
GRPN
ESPR
Relative Strength Index (RSI) 62.94 67.43
Support Level $15.97 $3.16
Resistance Level $27.99 $3.26
Average True Range (ATR) 2.15 0.02
MACD 0.04 -0.01
Stochastic Oscillator 76.30 78.57

Price Performance

Historical Comparison
GRPN
ESPR

About GRPN Groupon Inc.

Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: